Medico Remedies (NSE:MEDICO) Net Income From Continuing Operations : ₹83 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Medico Remedies Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Medico Remedies's net income from continuing operations for the three months ended in Mar. 2024 was ₹31 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ₹83 Mil.

Medico Remedies Net Income From Continuing Operations Historical Data

The historical data trend for Medico Remedies's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medico Remedies Net Income From Continuing Operations Chart

Medico Remedies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income From Continuing Operations

Get a 7-Day Free Trial

16.30

25.90

48.12

72.42

82.91

Medico Remedies Quarterly Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															17.66	13.20	24.26	14.45	30.99

Medico Remedies Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹83 Mil.

Medico Remedies (NSE:MEDICO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medico Remedies Ltd (NSE:MEDICO) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

540937:India

Address

N. S. Phadke Marg, Opposite Teligali, 1105/1106, 11th Floor, Hubtown Solaris, Andheri (East), Mumbai, MH, IND, 400069

Website

https://www.medicoremedies.com

Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It focuses on the production and marketing of anti-infective, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics, and other supplements. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.

Medico Remedies (NSE:MEDICO) Headlines

No Headlines